Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
eleanor.temple@ndorms.ox.ac.uk

Eleanor Temple

OCTRU Medical Statistician

Recent publications

Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial.

McManus RJ. et al, (2024), BMC Cardiovasc Disord, 24

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.

Sheppard JP. et al, (2024), Lancet Healthy Longev, 5, e563 - e573

Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial

Sheppard J. et al, (2024), The Lancet Healthy Longevity

Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial

Sheppard J. et al, (2024), Journal of Hypertension, 42, e109 - e110

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.

Kyle SD. et al, (2023), Lancet, 402, 975 - 987

More publications